Microembolization may outlast steroid shots for frozen shoulder

NCT ID NCT07696923

First seen Jul 10, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This study compares two treatments for frozen shoulder: a newer procedure called transcatheter arterial microembolization (TAME) and standard corticosteroid injections. TAME aims to reduce pain by blocking abnormal blood vessels in the shoulder, while steroids work by calming inflammation. The trial enrolls 94 adults with frozen shoulder and tracks pain, mobility, and quality of life over six months to see which approach offers better and longer-lasting relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcatheter arterial microembolization (TAME) and corticosteroid injection
What this could lead to
If TAME proves superior, it could offer a longer-lasting, non-surgical option for frozen shoulder relief.
What could go wrong
This is a single-center trial with 94 participants, so results may not apply broadly. TAME carries risks like temporary pain or artery spasm.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHESIVE CAPSULITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shin Kong Wu Ho-Su Memorial Hospital, Taipei,

    Taipei, 111, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.